Before You Write
A company can win on merit and still lose the award if its ownership or headcount has shifted by the award date. NIH tests eligibility at the time of award for both Phase I and Phase II, and the principal investigator's employment must hold through the whole project (PA-27-100). Settle ownership questions with counsel before the first draft.
Eligibility
NIH funds only US for-profit small business concerns that employ no more than 500 people, counting every affiliate, and that operate primarily within the United States. Ownership must be more than 50% held by US citizens or permanent residents, by other qualifying small businesses, or by an Indian tribe, ANC or NHO. Venture-backed companies qualify when several investment firms together hold the majority and no single firm holds more than half. A company in that position must attach a signed certification saved under the exact file name "SBIR Application VCOC Certification.pdf", since a renamed file can delay processing.
SBIR or STTR
The route depends on who does the work. Under SBIR, your company normally carries out at least two thirds of Phase I research and half of Phase II, with partners and consultants taking the rest. STTR is built for projects that depend on a formal collaboration with a university or other nonprofit research institution. The partner must perform at least 30% of the work and your company at least 40%, and the principal investigator can be employed by either side (NIH SEED). The award goes to your company under both programs. SBIR carries a far larger share of NIH money, with 3.2% of the extramural research budget against 0.45% for STTR, so choose STTR only when the partnership is real.
Choosing a Phase
Reviewers judge a Phase I application on whether its strategy will establish feasibility, manage the riskiest steps and set measurable milestones to reach before Phase II. Phase I normally lasts six months. Fast-Track combines both phases in one application, which suits a team that can already write a full Phase II plan and wants to close the funding gap between awards. If feasibility is already proven with other funding, Direct to Phase II skips the first phase altogether. After a Phase I award, keep Phase II eligibility by applying within the first six due dates after the Phase I budget period ends.
Choosing an Institute
NIH's Center for Scientific Review assigns every application to an institute, and you can request one on the PHS Assignment Request Form. Each institute publishes its own research priorities, budget waiver topics and contacts on NIH's Small Business Funding Considerations page. Call the program officer before writing. The program officer can confirm fit, point you to a better institute and tell you whether your study counts as a clinical trial under NIH's definition (sbir.org).
Registrations
Four accounts must be active before submission, and failing to finish them in time is not accepted as a reason for lateness.
- SAM.gov - issues your Unique Entity Identifier, and the registration has to be renewed every year.
- SBA Company Registry - issues the SBC Control ID you enter on the SBIR/STTR Information form.
- eRA Commons - needs at least one Signing Official and one principal investigator account. A PI who also signs for the company needs two separate accounts, and every PI profile must link to an ORCID ID.
- Grants.gov - opens only once SAM.gov registration is active.
NIH estimates six weeks or more for the full set, including three weeks or more for a first SAM.gov registration and two weeks or more for eRA Commons.